The ionic conductances that contribute to the slow wave appear to vary among species. In humans, a tetrodotoxin-resistant Na ϩ current (NaV1.5) encoded by SCN5A contributes to the rising phase of the slow wave, whereas T-type Ca 2ϩ currents have been reported from cultured mouse intestine ICC and also from canine colonic ICC. Mibefradil has a higher affinity for T-type over L-type Ca 2ϩ channels, and the drug has been used in the gastrointestinal tract to identify T-type currents. However, the selectivity of mibefradil for T-type Ca 2ϩ channels over ICC and smooth muscle Na ϩ channels has not been clearly demonstrated. The aim of this study was to determine the effect of mibefradil on T-type and L-type Ca 2ϩ and Na ϩ currents. Whole cell currents were recorded from HEK-293 cells coexpressing green fluorescent protein with either the rat brain T-type Ca 2ϩ channel ␣13.3b ϩ ␤2, the human intestinal L-type Ca 2ϩ channel subunits ␣1C ϩ ␤2, or NaV1.5. Mibefradil significantly reduced expressed T-type Ca 2ϩ current at concentrations Ն 0.1 M (IC50 ϭ 0.29 M), L-type Ca 2ϩ current at Ͼ 1 M (IC50 ϭ 2.7 M), and Na ϩ current at Ն 0.3 M (IC50 ϭ 0.98 M). In conclusion, mibefradil inhibits the human intestinal tetrodotoxin-resistant Na ϩ channel at submicromolar concentrations. Caution must be used in the interpretation of the effects of mibefradil when several ion channel classes are coexpressed. ion channel; gastrointestinal tract; patch clamp A SPECIALIZED SUBSET of interstitial cells of Cajal (ICC) generate the electrical slow wave, an important determinant of gastrointestinal motility. The inward ionic conductances involved in the generation of the slow wave appear to vary among species. In humans, a tetrodotoxin-resistant Na ϩ current, carried by the SCN5A-encoded Na V 1.5 channel, is expressed in intestinal ICC and contributes to the rising phase of the slow wave (20) . SCN5A has also been identified in human intestinal circular smooth muscle cells (18) but not in mice and pigs. In mice, T-type-like Ca 2ϩ currents have been reported from mouse colonic myocytes and mouse intestine ICC (11, 12) and are considered to contribute to properties of the slow wave. T-type Ca 2ϩ channels have also been described in canine colonic ICC (13) .
Mibefradil is a tetralol Ca 2ϩ channel antagonist with higher affinity for T-type (
2ϩ channels (summarized in Ref. 15) . Because the tetrodotoxin-resistant Na ϩ current and T-type Ca 2ϩ currents have fairly similar electrophysiological properties, mibefradil would be a useful tool to dissect out inward tetrodotoxinresistant Na ϩ currents and T-type Ca 2ϩ currents. Indeed, mibefradil has already been used in the gastrointestinal tract to identify a T-type-like current (11) . However, the selectivity of mibefradil for Ca 2ϩ currents compared with Na ϩ channels expressed in human gastrointestinal smooth muscle cells and ICC has not been clearly demonstrated. Therefore, we sought to determine the effect of mibefradil on Ca 2ϩ and Na ϩ channels expressed in HEK-293 cells.
MATERIALS AND METHODS
Expression vector construction and HEK-293 transfection. The expression vectors containing the human jejunum L-type Ca 2ϩ channel ␣ 1C (␣11.2)-and ␤2-subunits, the rat brain T-type Ca 2ϩ channel ␣ 13.3b-subunit, or the human jejunum Na ϩ channel SCN5A ␣-subunit were described previously (14, 17, 18) . The ␣ 13.3b-subunit clone was a gift from Dr E. Perez-Reyes. Using Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA), the green fluorescent protein (GFP) pEGFP-C1 (Clontech, Palo Alto, CA), and either the sodium or L-or T-type calcium channel, expression vectors were transiently cotransfected into HEK-293 cells (American Type Culture Collection, Manassas, VA). HEK cells expressing L-or T-type Ca 2ϩ channel subunits were cultured for 2 days, whereas cells expressing SCN5A were cultured for 1 day posttransfection. Transfected cells were identified by fluorescent microscopy and patch clamped to record whole cell currents.
Patch clamp recordings. Patch clamp recordings were obtained at 22°C using standard whole cell techniques (5, 6) . Microelectrodes were pulled from Kimble KG-12 glass on a P-97 puller (Sutter Instruments, Novato, CA). Electrodes were coated with R6101 (Dow Corning, Midland, MI) and fire polished to a final resistance of 3 to 5 M⍀. Currents were amplified, digitized, and processed using an Axopatch 200B amplifier, Digidata 1322A, and pCLAMP 8 software (Axon Instruments, Foster City, CA). Whole cell records were sampled at 10 kHz and filtered at 5 kHz with an eight-pole Bessel filter. In T-type Ca 2ϩ current experiments, cells were held at Ϫ100 mV and pulsed from Ϫ90 to ϩ35 mV in 5-mV intervals for 150 ms each. To record L-type Ca 2ϩ current, cells were held at Ϫ100 mV and pulsed from Ϫ60 to ϩ40 mV in 5-mV intervals for 50 ms each. For Na ϩ current experiments, we used a holding potential of between Ϫ100 to Ϫ75 mV and stepped from Ϫ80 to ϩ35 mV in 5-mV intervals for 50 ms each. Most cells were held at Ϫ100 or Ϫ90 mV, but when the Na ϩ currents were too large to be recorded accurately, the holding voltage was changed to a more depolarized voltage. Three cells were held at Ϫ80 mV and two cells at Ϫ75 mV. A 70 -80% series resistance compensation (lag of 60 s) was applied during each recording. Cell capacitance of HEK-293 cells tranfected with ␣ 13.3b ϩ ␤2 was 23 Ϯ 4 pF (n ϭ 12), ␣ 1C ϩ ␤2 was 19 Ϯ 3 pF (n ϭ 10), and SCN5A was 20 Ϯ 2 pF (n ϭ 18). The differences in cell capacitance between these groups were not significant (P Ͼ 0.05). Resistance after access was established was 5-10 M⍀. , and back to the control solution without the drug (Sigma-Aldrich, St. Louis, MO). Up to three concentrations were applied to any one cell. The bath chamber was rinsed with 1.5 ml NaCl Ringer ϩ mibefradil at 10 ml/min for ϳ9 s. Two recordings were taken at each concentration immediately after rinse and 2 min later. Intra-and extracellular solutions were equilibrated to pH 7.0, 300 mmol/kg and pH 7.35, 300 mmol/kg, respectively. We did not normalize for rundown in our experiments. We did not apply more than three concentrations to a particular cell to avoid long experiments. We have not observed rundown in cells transfected with SCN5A. Rundown for the L-type Ca 2ϩ current was about 15% over 10 min after peak inward current.
Data analysis. Data were analyzed using Clampfit (Axon Instruments, Union City, CA), Excel (Microsoft, Redmond, WA), and SigmaPlot (SPSS, Chicago, IL). For current-voltage graphs, the peak inward current of a single control trace was normalized to one using the equation I norm ϭ Ϫ1 ⅐ (IV/Imax), where Inorm is normalized current, IV is measured current at a given voltage, and Imax is maximum peak inward current of the control trace. Thus peaks of all other traces per cell were expressed as a fraction of 1. Statistical comparisons were made using a paired, two-tailed Student's t-test. Statistical significance was accepted when P values were Ͻ 0.05. Data are expressed as means Ϯ SE. Sigmoidal dose-response curves were built in SigmaPlot by inserting normalized peak current data into the equation:
. 
RESULTS

Effect of mibefradil on heterologously expressed T-type
to Ϫ48 Ϯ 9 pA 3 M, and Ϫ8 Ϯ 2 pA 10 M, n ϭ 6 for each concentration, P Ͻ 0.05 at 0.1-10 M). Only 10 Ϯ 3% of the control current returned 2 min after washing out mibefradil with multiple exchanges of fresh Ringer solution (Ϫ78 Ϯ 25 pA, n ϭ 6, P Ͻ 0.05 compared with predrug). current [Ϫ157 Ϯ 39 pA control; to Ϫ151 Ϯ 36 pA at 0.1 M (1 Ϯ 6% decrease), to Ϫ147 Ϯ 40 pA at 0.3 M (9 Ϯ 6% decrease), n ϭ 5; P Ͼ 0.05]. In separate experiments adding 1 M mibefradil to the extracellular solution resulted in a non- Fig. 1 . Block of expressed T-type Ca 2ϩ channel subunits ␣13.3b ϩ ␤2 by mibefradil. A: representative whole cell T-type Ca 2ϩ channel currents recorded in NaCl Ringer solution with 0, 0.1, 1, or 10 M mibefradil. B: current-voltage relationship for peak inward T-type Ca 2ϩ current was normalized to the maximum peak inward current of the control record. C: summary of the mean normalized peak T-type Ca 2ϩ current in cells exposed to 0 -10 M mibefradil (n ϭ 6 per concentration, *P Ͻ 0.05). significant 23 Ϯ 11% decrease in L-type Ca 2ϩ current (Ϫ55 Ϯ 11 pA control, to Ϫ38 Ϯ 4 pA 1 M, n ϭ 5, P Ͼ 0.05). However, increasing the dose to 3 or 10 M significantly blocked L-type current by 52 Ϯ 4 and 83 Ϯ 2%, respectively (Ϫ157 Ϯ 39 pA control to Ϫ69 Ϯ 12 pA 3 M, and Ϫ55 Ϯ 11 pA control to Ϫ9 Ϯ 1 pA 10 M, n ϭ 5 for each concentration, P Ͻ 0.05). Similar to T-type current, washout of mibefradil did not return L-type Ca 2ϩ current to normal (46 Ϯ 10% of predrug current, n ϭ 5, P Ͻ 0.05 compared with predrug). Therefore, an eightfold lower dose of mibefradil was needed to block T-than L-type current, supporting the literature that mibefradil is more specific for T-type Ca 2ϩ channels than L-type Ca 2ϩ channels. Effect of mibefradil on heterologously expressed ␣-subunit Na V 1.5 of the human jejunum Na ϩ channel encoded by SCN5A. Because Na ϩ and T-type Ca 2ϩ current both reach maximum peak inward current at potentials more negative than Ϫ20 mV, it would be useful to have a pharmacological tool to discern these currents. We determined the sensitivity to mibefradil of the human jejunum Na ϩ channel ␣-subunit expressed in HEK cells (Fig. 3) . Switching the concentration of mibefradil in the extracellular solution from 0 to 0.1 M resulted in a nonsignificant change in Na ϩ current (Ϫ1096 Ϯ 202 pA 0 M control, to Ϫ1033 Ϯ 174 pA 0.1 M, ⌬ 4 Ϯ 3%, n ϭ 6, P Ͼ 0.05). Increasing the concentration to 0.3 M significantly decreased Na ϩ by 34 Ϯ 4% (Ϫ1096 Ϯ 202 pA 0 M, to Ϫ657 Ϯ 139 pA 0.3 M, n ϭ 6, P Ͻ 0.05). A further increase in extracellular mibefradil concentration to 1, 3, and then 10 M significantly blocked Na ϩ current by 47 Ϯ 9, 72 Ϯ 4, and 96 Ϯ 2%, respectively (Ϫ883 Ϯ 102 pA 0 M, to Ϫ495 Ϯ 103 pA at 1 M, to Ϫ346 Ϯ 86 pA at 3 M, to Ϫ33 Ϯ 16 pA at 10 M, n ϭ 6, P Ͻ 0.05 comparing either concentration to control). Of the initial Na ϩ current, 42 Ϯ 8% recovered after a 2-min washout (Ϫ1052 Ϯ 123 pA predrug to Ϫ395 Ϯ 83 pA postdrug, n ϭ 15, P Ͻ 0.05).
Effect of mibefradil on heterologously expressed human jejunum L-type
Selectivity of mibefradil to T-type Ca 2ϩ
, L-type Ca 2ϩ , and Na ϩ currents. To determine the relative selectivity of the Tand L-type Ca 2ϩ vs. Na ϩ current, we plotted the log concentration/response relationship for mibefradil against normalized peak currents (Fig. 4) . Mibefradil was most selective for the T-type Ca 2ϩ channel ␣ 1 3.3b ϩ ␤ 2 (IC 50 ϭ 0.29 M), followed by the Na ϩ channel SCN5A (IC 50 ϭ 0.98 M), and the L-type Ca 2ϩ channel ␣ 1C ϩ ␤ 2 (IC 50 ϭ 2.7 M).
DISCUSSION
Coordinated gastrointestinal motility requires a complex interaction between several cell types, including nerves, smooth muscle cells, and ICC. Different classes of ICC are present in the gastrointestinal tract and appear to subserve different functions. At least three different functions have been ascribed to ICC (1, 9, 20, (23) (24) (25) . ICC act to modulate neuronal signals to smooth muscle cells (1, 23, 25) , may serve as mechanotransducers (20) , and generate and amplify the pacemaker signal and the slow wave (9, 24). The slow wave recorded from smooth muscle cells originates from ICC and is an important determinant of smooth muscle function, with the frequency of the slow wave setting the frequency of smooth muscle contraction, and the amplitude of the slow wave contributing to the control of the strength of smooth muscle contractions. The rhythmic depolarization of smooth muscle membrane potential opens L-type Ca 2ϩ channels expressed in smooth muscle allowing Ca 2ϩ entry and initiation of contractions (4) .
Ionic conductances that underlie the pacemaker signal and upstroke of the slow wave are not well understood and appear to vary between species. In cultured mouse small intestinal ICC, both chloride channels (10, 26) and Ca 2ϩ -permeable nonselective cation channels of the TRP family have been proposed as the pacemaker channel (22) . In dogs (13) and mice (11), a T-type channel has been reported to be expressed in ICC and in humans, a Na ϩ channel (20) . The Na ϩ channel is not the pacemaker channel but contributes to the upstroke of the slow wave and its regulation by stretch (19, 20) . With several different candidates with overlapping electrophysiological properties, it is difficult to interpret intact muscle strip experiments, yet these experiments are necessary to integrate information obtained at a channel level often under culture conditions that may alter the expression of ion channels. Pharmacological and electrophysiological experiments at the muscle strip level are therefore often needed, and drugs that discriminate between the candidate ion channels are required. QX314 is a quaternary membrane-impermeant derivative of lidocaine that is used as a Na ϩ channel blocker (3, 7, 21 ) and when applied externally has different effects on neuronal and cardiac Na ϩ channels, including Na v 1.5 (2, 8, 20) . QX314 is therefore useful to discriminate between nonselective cation channels, Ca 2ϩ -selective channels, and Na ϩ channels; however, QX314 at 500 M also inhibits about 30% of T-type Ca 2ϩ current (unpublished data) and its mechanism of action Fig. 3 . Block of Na ϩ channel ␣-subunit SCN5A by mibefradil. A: representative whole cell Na ϩ channel currents recorded in NaCl Ringer's solution with 0, 1, or 10 M mibefradil. B: current-voltage relationship for peak inward Na ϩ current was normalized to the maximum peak inward current of the control record. C: summary of the mean normalized peak Na ϩ current in cells exposed to 0 -10 M mibefradil (n ϭ 6 per concentration, *P Ͻ 0.05). Fig. 4 . Dose-response curves representing mibefradil inhibition of Na ϩ and Land T-type Ca 2ϩ channels. Summary of mibefradil concentration vs. normalized peak currents as shown in Figs. 1C, 2C , and 3C. IC50 values for T-type Ca 2ϩ , Na ϩ , and L-type Ca 2ϩ channels were (in M) 0.29 (␣13.3b ϩ ␤2, n ϭ 6), 0.98 (SCN5A, n ϭ 6), and 2.7 (␣1C ϩ ␤2, n ϭ 5), respectively. requires a prolonged application time (8, 20) . Mibefradil has been used as a selective T-type Ca 2ϩ channel blocker (11, 12) , and the data provided in this report and the literature (summarized in Ref. 15 ) suggests that at concentrations below 1 M it indeed can discriminate between ␣ 1C -L-type and the ␣ 1 3.3b-T-type Ca 2ϩ channels. Published data for the IC 50s (in 2 mM Ca 2ϩ ) for ␣ 1 3.1 (␣1G, 0.27 M) and ␣ 1 3.2 (␣ 1H , 0.14 M) also suggest that mibefradil can discriminate between T-type Ca 2ϩ channels containing other ␣-subunits and ␣ 1C -L-type Ca 2ϩ channels (15) . However, the data from this report and a recently published report (16) also suggest that, with an IC 50 of 0.29 M for the ␣ 1 3.3b-T-type Ca 2ϩ channel and an IC 50 of 0.98 M for Na v 1.5, mibefradil cannot be used to discriminate between the two channel types, and caution must be used in the interpretation of the effects of mibefradil as a blocker of T-type Ca 2ϩ channels when, as is nearly always the case, more than one channel type is expressed in a given cell type.
